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erythrocyte recovery; 82% and 24.3% for platelets and leukocytes,
respectively; 97.8% for heparin).
Cell-derived microparticles are, on average, smaller in diameter
than platelets and range in size from about 100 nm to 1.0 m. Thus,
the largest microparticles may overlap in size with platelets, which on
average range in from 1.0 m to 5.0 m. Both erythrocyte-derived
microparticles and platelet-derived microparticles were removed ef-
ficiently (97% and 99%; P  0.002 and P  .001, respectively).
Interestingly, the efficiency of the Cell Saver device to remove
platelet-derived microparticles as well as erythrocyte-derived mi-
croparticles was significantly increased compared with the effi-
ciency to remove thrombocytes (P  .019 and P  .002, respec-
tively; Wilcoxon signed rank test). Thus, cell-derived vesicles,
which on average are smaller in diameter than thrombocytes, are
removed more efficiently from blood by a Cell Saver device than
thrombocytes in a clinical setting.
This study is the first to directly evaluate the efficiency of a Cell
Saver device to remove cell-derived microparticles from patient
blood. Our data show that a Cell Saver device efficiently reduces
the numbers of coagulation- and inflammation-promoting micro-
particles. From these data we cannot exclude that microparticles
may bind to cells present within the blood or that low numbers of
microparticles are generated by cell activation during the passage
of blood through the Cell Saver device.
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Primary intrapulmonary thymoma associated with congenital
hyperhomocysteinemia
Alessando Stefani, MD,a Edouard Boulenger, MD,b Sylvie Mehaut, MD,c Adrian Ciupea, MD,c and Marco Alifano, MD,a
Paris and Troyes, France
Primary intrapulmonary thymomas (PITs) are very un-common, with 28 cases reported to date.1-3 Because ofthe paucity of studies, the biologic behavior and patho-logic features of these neoplasms are not well known.
The C677T methylenetetrahydrofolate reductase (MTHFR) geno-
type is a congenital disorder leading to low folate levels; the
resultant mild hyperhomocysteinemia is associated with increased
risk of venous thromboembolism and malignancies.4,5
We present a case of PIT associated with hyperhomocysteine-
mia caused by the C677T variant of MTHFR.
Clinical Summary
A 73-year-old woman was admitted for acute dyspnea with bron-
chospasm in a chronic obstructive pulmonary disease pathologic
substrate. Her medical history was marked by episodes of venous
thrombosis caused by a mutation of the MTHFR gene that imposed
a preventive anticoagulant therapy. Chest radiography revealed an
18-mm nodule in the right upper lobe, which was confirmed by a
computed tomographic scan (Figure 1). A positron emission to-
mographic scan showed a moderate uptake in correspondence of
the lesion (standardized uptake value, 2.2). The results of bron-
choscopy and computed tomographic scanning of the brain were
normal.
A primary pulmonary tumor was suspected. Thoracotomy was
performed by one of us (E.B.), and a nodule was found in the right
upper lobe close to the hilum. Frozen examination revealed cells of
uncommon feature suspected for malignancy. A right upper lobec-
tomy with full nodal dissection was performed.
Macroscopic examination showed a well-circumscribed and
encapsulated nodule (Figure 2, a ). Histologic evaluation re-
vealed the presence of 2 cell populations: epithelioid and lym-
phocytic (Figure 2, b ). The epithelioid component was predom-
inant and admixed with scattered lymphocytes. No areas of
necrosis and very few mitoses could be identified. Immunohis-
tochemical analysis demonstrated strong staining for cytokera-
tin 5 and 6 and epithelial membrane antigen in the epithelioid
component, with negative staining for cytokeratin 7, thyroid
transcription factor 1, and calretinine. These histologic findings
were consistent with mixed or type AB thymoma. All lymph
nodes were free of tumor.
The postoperative course was uneventful, and the patient is free
of recurrence 2 years after the operation.
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Discussion
To our knowledge, 29 cases of PIT have been described, including
this one.1-3 Pathogenesis is still a subject of debate: the most
supported theory is that these tumors derive from ectopic thymic
tissue, resulting from an embryologic displacement, but a terato-
matous origin has also been invoked.1
The number of tumors reported is too small to clearly predict
their biologic behavior. PITs occurred usually from the sixth
decade of life,1-3 and a slight female predominance has been
found.3 The right side was more often affected,1 with no prefer-
ence in hilar or peripheral location.2 Patients were more commonly
asymptomatic.3
Thehistologicspectrumof these lesionsrangesfromlymphocyte-
rich to predominantly epithelioid to spindle-cell thymoma.1 In
most cases tumors appeared as well-circumscribed lesions, with
low mitotic activity and minimal atypia. PIT might represent a
serious diagnostic challenge for the pathologist; the differential
diagnosis includes lymphoma and primary or metastatic carci-
noma of the lung. Immunohistochemical stains might be of aid,
but morphologic features are of basic importance.1
Most reported cases of PIT were slow-growing tumors with
a good prognosis when surgically resected.1-3 Because preop-
erative diagnosis, either on biopsy specimens or frozen sec-
tions, is very difficult, PITs are usually diagnosed postopera-
tively. Therefore indications about the surgical management are
difficult to define and to apply (eg, type of resection or need for
mediastinal dissection).
Our case was classified as a type AB thymoma, an essentially
nonaggressive lesion; it confirms the low grade of malignancy of
PIT and its favorable outcome if completely resected.
The association between PITs and myasthenia gravis is less
frequent than for mediastinal thymomas. As far as we know, 3
patients with PIT had symptoms of myasthenia gravis, whereas
other syndromes associated with mediastinal thymomas have
never been described for PITs.
The C677T variant of the MTHFR gene is an inherited
congenital disorder altering the metabolism of folic acid.4 The
resulting low folate levels influence the homocysteine remethy-
lation pathway, and this results in mild hyperhomocysteinemia.
Increased levels of homocysteine have been related to an in-
creased risk of venous thromboembolism, pregnancy loss,
anomalous progeny, cancer (eg, hematologic malignancies),
and brain and colon tumors.4,5 Our patient had the heterozygous
variant of the C677T MTHFR genotype, which induces inter-
mittent moderate hyperhomocysteinemia and leads to recurrent
venous thromboses. Although the vascular toxicity of hyperho-
mocysteinemia is well demonstrated, the association between
Figure 1. Chest computed tomographic scan showing a nodule in
the anterior segment of the right upper lobe. The lesion appeared
well-circumscribed and heterogeneous (42 and 106 Hounsfield
units in the superior and inferior part, respectively).
Figure 2. The photograph (a) shows a whitish, well-encapsulated
tumor (black arrow) within the parenchyma of the right upper lobe.
The microphotograph (b) show a peripheral type AB mixed area
(right) close to the lung parenchyma (left) with an epithelioid pop-
ulation composed of large, round- to oval-shaped epithelial cells
alternating with areas showing a spindle-cell morphology, sepa-
rated by thin connective tissue strands, and accompanied by a
sprinkling of mature small lymphocytes (hematoxylin and eosin stain).
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altered levels of this thiol and cancer is a recent acquisition, and
its clinical significance has yet to be defined. This is the first
article reporting an association between MTHFR variant/hyper-
homocysteinemia and thymoma, supporting the role of hyper-
homocysteinemia as a risk factor for cancer.
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Anterior transclavicular approach to malignant tumors of the thoracic
inlet: Importance of the scapulothoracic articulation
Marc de Perrot, MD,a and Raja Rampersaud, MD,b Toronto, Canada
T he anterior transclavicular approach for lung cancerinvading the thoracic inlet was described by Dartevelleand colleagues.1 Although this approach provides ex-cellent exposure to the thoracic inlet, it has often been
criticized because of potential deformity and dysfunction of the
shoulder related to resection of the clavicle. However, the proxi-
mal part of the clavicle plays a minor role in the stability and
function of the shoulder as long as the integrity of the scapulotho-
racic articulation is preserved.2,3 The scapulothoracic articulation
is formed by the attachment of the scapula to the chest wall
through the trapezius, latissimus dorsi, rhomboid, levator scapulae,
and serratus anterior muscles.4,5 Thus, preservation of these mus-
cles and their nerves is crucial to achieve good functional and
cosmetic results. We emphasize the importance of preserving the
spinal accessory, dorsal scapular, and long thoracic nerves that are
running in the posterior cervical triangle and innervate the trape-
zius, rhomboid, and serratus anterior muscles, and we document
the good functional and cosmetic results obtained with this ap-
proach despite resection of the clavicle if the scapulothoracic
articulation is preserved.
Clinical Summary
The anterior transclavicular approach has been described in detail,1
and we will therefore limit our description to some specific points
only. An incision is made along the sternocleidomastoid muscle
and extended horizontally along the third rib. The extension of the
incision ranges from the level of the jaw down to the third rib to
permit optimal exposure of the thoracic inlet and pulmonary hilum.
The sternocleidomastoid and pectoralis major muscles are dis-
sected off the chest wall and elevated together with the skin as a
myocutaneous flap. The preservation of a myocutaneous flap is
important to obtain adequate healing of the wound. The clavicle is
freed up to the point where the subclavian vein crosses behind the
clavicle.
The spinal accessory nerve should be identified in the upper
part of the cervical incision at the posterior edge of the sternoclei-
domastoid muscle lateral to the internal jugular vein. The nerve
then runs in the posterior cervical triangle in front of the levator
scapulae and trapezius muscles, which form the lateroposterior
border of the surgical field behind the elevated myocutaneous flap
(Figure 1).
Division of the scalenus anterior muscle will expose the bra-
chial plexus and the subclavian artery. At this point, branches of
the fifth (C5), sixth (C6), and seventh (C7) cervical nerve roots
passing through the body of the scalenus medius muscle can be
identified emerging on the lateral aspect of this muscle just above
the brachial plexus (Figure 1). These small branches (1-2 mm)
must be preserved when the scalenus medius muscle is divided
from the first rib because they will form the dorsal scapular
(branches of C5) and long thoracic nerves (branches of C5, C6,
and C7) innervating the rhomboid and serratus anterior muscles,
respectively.
Division of the first and second rib at the costosternal junction
and the third rib along the posterior axillary line provides excellent
exposure to the pulmonary hilum to perform the upper lobectomy
and mediastinal lymph node dissection (Figure 1). If involved by
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